small molecule

SELENIOUS ACID

Loss of exclusivity—loss of exclusivity

CompanyCipla →See this company's full patent-cliff portfolio

Drug detail

Brand name	SELENIOUS ACID
Active ingredient	SELENIOUS ACID
Strength	EQ 600MCG SELENIUM/10ML (EQ 60MCG SELENIUM/ML)
Dosage form	SOLUTION
Route	INTRAVENOUS
Modality	Small molecule
FDA approval	July 2025
Marketing status	DISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.